India's government has released strict rules for GLP-1 drugs, used for diabetes and obesity. These powerful medications are now prescription-only, requiring specialist doctors. Unsupervised sales are banned. Inspections are increasing, with penalties for rule-breakers. Patients must use these drugs only under medical care to avoid side effects. This move ensures safe use and protects public health.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tRfbqPg
via IFTTT
No comments:
Post a Comment